NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Astha Lamichhane
University of Akron - Akron / United States
Engineering & Technology / Biomedical Engineering
AD Scientific Index ID: 5157513
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Astha Lamichhane's MOST POPULAR ARTICLES
1-)
Therapeutic targeting of stromal-tumor HGF-MET signaling in an organotypic triple-negative breast tumor modelS Singh, A Lamichhane, P Rafsanjani Nejad, J Heiss, H Baumann, ...Molecular Cancer Research 20 (7), 1166-1177, 2022112022
2-)
Modeling adaptive resistance of KRAS mutant colorectal cancer to MAPK pathway inhibitors with a three-dimensional tumor modelP Shahi Thakuri, A Lamichhane, S Singh, M Gupta, GD Luker, H TavanaACS Pharmacology & Translational Science 3 (6), 1176-1187, 2020112020
3-)
Therapeutic targeting of cancer stem cells prevents resistance of colorectal cancer cells to MEK inhibitionA Lamichhane, P Shahi Thakuri, S Singh, P Rafsanjani Nejad, J Heiss, ...ACS Pharmacology & Translational Science 5 (9), 724-734, 2022102022
4-)
Modeling adaptive drug resistance of colorectal cancer and therapeutic interventions with tumor spheroidsA Lamichhane, PS Thakuri, P Rafsanjani Nejad, H TavanaExperimental Biology and Medicine 246 (22), 2372-2380, 202192021
5-)
Toxicity of combinations of kinase pathway inhibitors to normal human cells in a three-dimensional cultureP Rafsanjani Nejad, P Shahi Thakuri, S Singh, A Lamichhane, J Heiss, ...SLAS TECHNOLOGY: Translating Life Sciences Innovation 26 (3), 255-264, 202152021
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept